Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression

Clinical Trials, Metastatic Castration Sensitive Prostate Cancer (MCSPC)

— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives

NCT Number: NCT05683964
Phase: Early Phase 1
Trial Summary: The goal of this research study is to determine whether hormonal therapies used early in the course of prostate cancer could increase the amount of Prostate-Specific Membrane Antig – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Beth Israel Deaconess Medical Center
Acronym:

Pin It on Pinterest